Lepu Medical: 2025 annual performance report of independent directors (Wang Lihua)
Lepu (Beijing) Medical Equipment Co., Ltd.
Independent director’s work report
Lepu (Beijing) Medical Equipment Co., Ltd.
Independent Director Annual Work Report
2025
(Wang Lihua)
As an independent director of Lepu (Beijing) Medical Devices Co., Ltd. (hereinafter referred to as the "Company"), due to the expiration of my term, I have officially resigned after a new independent director was elected at the first extraordinary shareholders meeting of 2026 held by the company on March 20, 2026. My term of office is from April 21, 2020 to March 20, 2026. During the above reporting period, I strictly followed the "Company Law of the People's Republic of China", "Measures for the Administration of Independent Directors of Listed Companies", "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies" and other laws, regulations and normative documents, as well as the "Articles of Association" In accordance with the provisions of the "Independent Director Work System", the Company shall conscientiously, diligently and independently perform the duties of an independent director, actively participate in the work of the company's board of directors and various special committees, prudently review various major proposals, effectively exert the supervisory and professional guidance role of independent directors, and effectively safeguard the legitimate rights and interests of the company and all shareholders, especially small and medium-sized shareholders. The performance of duties during the reporting period is now reported as follows:
1. Basic information of independent directors
Born in 1963, Chinese nationality, no permanent residence abroad, graduate degree, Master of Laws, practicing lawyer. He once served as director of the Scientific Research and Postgraduate Office of the Department of Law of Peking University, member of the Party Committee and assistant to the department director of the Department of Law of Peking University, director and secretary of the Party Committee of Beijing Tianyuan Law Firm, director of the fourth council of the Beijing Lawyers Association and director of the Disciplinary Committee, executive director of the fifth and sixth sessions of the Beijing Lawyers Association and director of the Disciplinary Committee, vice president of the seventh council of the Beijing Lawyers Association, and national lawyer. Executive deputy director of the Disciplinary Committee of the Chinese Teachers Association, member of the 7th and 8th Stock Issuance Review Committee of the China Securities Regulatory Commission, part-time member of the original 3rd, new 1st, 2nd, and 3rd Listed Company Mergers, Acquisitions and Reorganization Review Committees of the China Securities Regulatory Commission, deputy to the 14th People’s Congress of Xicheng District, Beijing and deputy director of the Internal Affairs Judicial Committee of the Standing Committee of the District People’s Congress, and vice president of the Beijing Intellectual Property Law Research Association. Currently, he is the chief partner of Beijing Tianyuan Law Firm, an independent director of China Minsheng Capital Holdings Co., Ltd., an independent director of Tianyang Hongye Technology Co., Ltd., an arbitrator of the Shenzhen Court of International Arbitration, and an arbitrator of the Beijing Arbitration Commission.
During the reporting period, I conducted an independent self-examination in strict accordance with the "Administrative Measures for Independent Directors of Listed Companies" and confirmed that I had no interest in the company, the company's controlling shareholders, actual controllers, shareholders holding more than 5% of the shares, and other directors, supervisors, and senior managers of the company, that there were no circumstances that would affect my independence, and that I had the professional ability and independent performance conditions required to perform my duties.
Lepu (Beijing) Medical Equipment Co., Ltd.
Independent director’s work report
2. Performance of duties during the reporting period
During my tenure in 2025, I have always adhered to the principles of loyalty, diligence and independence as my duty performance standards, actively participated in corporate governance, and conscientiously completed various duty performance tasks. I have not committed any violation of the requirements for independent directors to perform their duties. The specific performance of my duties is as follows:
(1) Meeting attendance and voting status
Board of Directors and shareholders’ meetings: During the reporting period, the company held a total of 7 board meetings and 3 shareholders’ meetings. All board of directors attended in person (on site/by communication) and did not attend the shareholders’ meeting. When participating in board meetings, carefully review the meeting materials in advance, inquire with the management on key issues in the proposals, exercise voting rights in an objective and fair manner based on a full understanding of the background information, and vote in favor of all proposals submitted to the board of directors for review during the reporting period, with no objections or abstentions.
Special committees and special meetings of independent directors: As the chairman of the remuneration and assessment committee, a member of the nomination committee, and a member of the audit committee of the company's board of directors, the remuneration and assessment committee held 2 meetings during the reporting period. I personally attended and presided over the meetings, taking the lead in reviewing relevant proposals to ensure that the special committees performed their duties in a standardized and effective manner; the audit committee was convened 5 times, and the proposals were carefully reviewed, and the committee reviewed the contents of the proposals carefully, and cooperated with the review of the company's financial audit, regular reports and other matters; the nomination committee was held once in 2026.
During the reporting period, due to the company's review of proposals such as "Estimation of Daily Related Transactions in 2025", "About Changing the Use of Partially Raised Funds for Raised Investment Projects and Related Matters", "About Using Part of Idle Raised Funds to Temporarily Supplement Liquidity" and "About Using Raised Funds to Replace Self-raised Funds Pre-invested in Raised Investment Projects", the company held 2 special meetings of independent directors. I attended in person and jointly conducted special deliberations on relevant matters with other independent directors and issued independent opinions to ensure that decision-making was in line with the interests of small and medium-sized shareholders.
- Exercise of voting rights: During the reporting period, I did not exercise the special powers stipulated in the "Administrative Measures for Independent Directors of Listed Companies" and did not raise any objections to the resolutions of the board of directors. All matters under review were voted on as required.
(2) On-site work and company operation research
During the reporting period, I strictly complied with the requirements for independent directors to perform their duties. Make full use of the opportunity to attend special meetings of the board of directors, special committees and independent directors to gain an in-depth understanding of the company's production and operation, financial status, use of raised funds, internal control implementation, etc., and timely grasp the progress of the company's major events through interviews and exchanges with the company's chairman, general manager, financial director, internal audit director, etc., focusing on the completion of the company's operating goals, core business development, and the impact of changes in the industry competition pattern on the company.
In the daily performance of my duties, I maintain close contact with the company's management through communications, phone calls, etc., and
Lepu (Beijing) Medical Equipment Co., Ltd.
Independent director’s work report
Keep informed of the company's various operating decisions and the progress of major events, and put forward targeted suggestions based on the company's development strategy and operational management issues based on its own professional knowledge and industry experience to provide a reference for the company's board of directors to make scientific decisions. At the same time, we will continue to pay attention to relevant media and Internet reports on the company, keep abreast of market evaluations and feedback on the company, and effectively perform supervision responsibilities.
(3) The company’s cooperation in performance of duties
During the reporting period, the company's management and relevant departments such as the Board of Directors Office, Securities Department, and Finance Department provided comprehensive and active cooperation and support for my performance of duties: before various meetings, meeting materials and relevant background explanations were provided in a timely and complete manner, and I responded to my inquiries in detail and Accurate responses; during on-site investigation, coordinate the heads of various departments to cooperate in introducing the situation and provide relevant information; during the decision-making process of major matters, fully solicit the opinions of independent directors, effectively protect my right to know, supervise and make decisions, and provide good conditions for me to effectively perform the duties of an independent director.
3. Matters of focus and review during the reporting period
During the reporting period, I focused on and carefully reviewed the core major issues in the company's operation and development, and issued clear consent opinions. The decision-making procedures for relevant matters were legal and compliant, and did not harm the interests of the company and all shareholders. The details are as follows:
(1) Remuneration proposals for directors and senior managers
As the chairman of the Remuneration and Appraisal Committee, I have carefully reviewed the proposals of "Director's Allowance for 2025", "Performance Appraisal Opinions for Senior Management in 2024 and Basic Salary Plan for Senior Management in 2025". After verification, the company's 2025 salary and allowance plan is formulated based on industry standards, company operating conditions and job performance requirements, and is reasonable and motivating.
(2) Review of financial accounting reports and periodic reports
As a member of the Audit Committee, I reviewed the company's "2024 Annual Report Full Text and Summary", "2024 Financial Final Report", "2024 Internal Control Evaluation Report", "2025 Semi-Annual Report Full Text and Summary", "2025 First Quarter Report" and "2025 Third Quarter Report" and other proposals, and conducted detailed verification of the financial data, operating results, internal control construction and other contents in the report. After verification, the company's periodic reports are prepared in compliance with the "Accounting Standards for Business Enterprises" and relevant laws and regulations. The financial information truly, accurately and completely reflects the company's actual operating conditions; the internal control system is sound and effectively implemented. The internal control evaluation report objectively discloses the company's internal control construction and operation, and there are no false records, misleading statements or major omissions.
(3) Audit agency renewal matters
Lepu (Beijing) Medical Equipment Co., Ltd.
Independent director’s work report
I reviewed the "Proposal on Re-appointing the Company's Audit Institution for 2025" and conducted a comprehensive review of the practicing qualifications, professional capabilities, performance records, independence, etc. of the accounting firm proposed to be re-appointed. After verification, the accounting firm has the legal qualifications for auditing services for listed companies. It has been diligent and responsible in providing audit services to the company in the past, and can issue audit reports objectively and fairly. The renewal matters meet the company's audit work needs, and the decision-making procedures are legal and compliant.
(4) Matters concerning the general election of the company’s board of directors
As my term is about to expire, the company launched the by-election of independent directors in March 2026. I carefully reviewed the "Proposal on the By-election of Independent Directors of the Sixth Board of Directors" and other relevant proposals, and carefully reviewed the resumes, professional experience, professional abilities, independence and other information of the independent director candidates. After verification, the independent director candidates have the qualifications and abilities to serve as company directors and meet the requirements of the Company Law, the Code of Corporate Governance for Listed Companies and the Articles of Association. The nomination process is legal and effective, and can inject new vitality into the company's board of directors and promote the improvement of corporate governance levels.
(5) Use and management of raised funds
I continue to pay attention to the storage and use of the company's raised funds, and strictly verify the use of raised funds by reviewing the raised funds special account verification report, bank statements, etc. After verification, the company's raised funds are managed in strict accordance with the "Supervisory Rules for Listed Companies' Raised Funds" and the company's "Raised Funds Management System", and are deposited in special accounts and used for special purposes. Investment projects with raised funds are progressing as planned. There is no illegal misappropriation or change of the investment direction of raised funds, and there is no behavior that harms the interests of the company and shareholders.
4. Other performance of duties
During the reporting period, I did not propose to convene a board of directors or propose to dismiss the accounting firm; I did not independently hire an external audit agency or consulting agency; I did not raise any objection to any proposal reviewed by the company's board of directors; I strictly abided by the company's "Insider Information Insider Registration and Management System" and other rules and regulations, did not use inside information to buy or sell the company's stocks, and did not commit any violation of the discipline of independent directors in performing their duties.
5. Duty Performance Summary and Resignation Speech
During my tenure as an independent director of the company, I have always strictly followed the laws, regulations and company system requirements, faithfully performed my duties as an independent director, participated in corporate governance diligently, independently and objectively, and given full play to the professional advantages and supervisory role of an independent director by attending meetings, on-site surveys, communication and supervision, and deliberation of major matters. I have provided professional support for the scientific decision-making of the company's board of directors, and effectively safeguarded the legitimate rights and interests of the company and all shareholders, especially small and medium-sized shareholders.
Lepu (Beijing) Medical Equipment Co., Ltd.
Independent director’s work report
During the reporting period, the company's governance structure was improved, the decision-making procedures were legal and compliant, the management was diligent and responsible, and had clear business ideas. The company's various operating tasks were steadily advanced, the independent directors' rights to perform their duties were fully protected, and the environment for performing their duties was good. I am resigning due to the expiration of my term. I would like to express my sincere gratitude to the company's board of directors, management and all employees for their trust, support and cooperation during the performance of their duties!
Independent Director:
Wang Lihua
April 23, 2026